Positive One-Year Results of PALS Program Published in Prestigious Rheumatology Journal kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.
NEW YORK, Oct. 26, 2023 /PRNewswire/ Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, is proud to share that the successful results of the Patient Advocates for Lupus Studies (PALS) pilot study were recently published in The Open Rheumatology Journal, the official open-access journal of the American College of Rheumatology. The PALS (Patient Advocates for Lupus Studies) Program was created to increase knowledge, positive attitudes toward, and intentions
The Lupus Research Alliance and its affiliate Lupus Therapeutics presented data at ACR Convergence 2022 with results showing the effectiveness of a pilot peer education program called the Patient Advocates for Lupus Studies (PALS), in increasing knowledge, perception, and willingness among people with Systemic Lupus Erythematosus (SLE) to participate in clinical trials.